TrialThe Journal of antimicrobial chemotherapy2016

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.

Laura L Kovanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.